5amf
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='5amf' size='340' side='right' caption='[[5amf]], [[Resolution|resolution]] 1.75Å' scene=''> | <StructureSection load='5amf' size='340' side='right' caption='[[5amf]], [[Resolution|resolution]] 1.75Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5amf]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5AMF OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5AMF FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[5amf]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5AMF OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5AMF FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NA:SODIUM+ION'>NA</scene>, <scene name='pdbligand=TWL:ETHYL+(5R)-4,5,6,7-TETRAHYDRO-1H-INDAZOLE-5-CARBOXYLATE'>TWL</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NA:SODIUM+ION'>NA</scene>, <scene name='pdbligand=TWL:ETHYL+(5R)-4,5,6,7-TETRAHYDRO-1H-INDAZOLE-5-CARBOXYLATE'>TWL</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5ame|5ame]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5ame|5ame]]</td></tr> | ||
| Line 10: | Line 10: | ||
== Function == | == Function == | ||
[[http://www.uniprot.org/uniprot/BRD1_HUMAN BRD1_HUMAN]] Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity.<ref>PMID:16387653</ref> <ref>PMID:21880731</ref> | [[http://www.uniprot.org/uniprot/BRD1_HUMAN BRD1_HUMAN]] Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity.<ref>PMID:16387653</ref> <ref>PMID:21880731</ref> | ||
| - | |||
| - | ==See Also== | ||
| - | *[[Bromodomain-containing protein|Bromodomain-containing protein]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Human]] | ||
[[Category: Arrowsmith, C H]] | [[Category: Arrowsmith, C H]] | ||
[[Category: Bountra, C]] | [[Category: Bountra, C]] | ||
Revision as of 20:26, 24 January 2018
Crystal structure of the bromodomain of human surface epitope engineered BRD1A in complex with 3D Consortium fragment Ethyl 4,5,6,7- tetrahydro-1H-indazole-5-carboxylate (SGC - Diamond I04-1 fragment screening)
| |||||||||||
Categories: Human | Arrowsmith, C H | Bountra, C | Bowkett, D | Bradley, A | Brandao-Neto, J | Brennan, P | Burgess-Brown, N | Collins, P | Cox, O | Delft, F von | Douangamath, A | Edwards, E | Fairhead, M | Krojer, T | Ng, J T | Pearce, N M | Strain-Damerell, C | Talon, R | Wright, N | Bromodomain | Diamond i04-1 | Epigenetic | Fragmentscreening | Histone-binding protein | Sgc | Structural genomic
